Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL6947334

Cc1ccc(CN)cc1.N

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ TAAR1 Q96RJ0 2/20 0.59
▸ CYP1A2 P05177 1/20 0.59
▸ CYP2A6 P11509 1/20 0.59
▸ HRH3 Q9Y5N1 1/20 0.55
▸ LOXL2 Q9Y4K0 5/20 0.52
▸ AGXT P21549 2/20 0.50
▸ IDO1 P14902 2/20 0.50
▸ ABAT P80404 1/20 0.50
▸ ACHE P22303 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ PSIP1 O75475 1/20 0.44
▸ NOS3 P29474 1/20 0.44
▸ NOS1 P29475 1/20 0.44
▸ NOS2 P35228 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11699 0.97 — —
Iodide SCHEMBL31425559 0.94 TAAR1 (0.59) TAAR1CYP1A2CYP2A6HRH3LOXL2
Hydrochloric Acid SCHEMBL1938665 0.94 TAAR1 (0.59) TAAR1CYP1A2CYP2A6HRH3LOXL2
SCHEMBL29277663 0.94 — —
Bromide SCHEMBL31513706 0.94 TAAR1 (0.59) TAAR1CYP1A2CYP2A6HRH3LOXL2
SCHEMBL260102 0.89 HRH3 (0.74) TAAR1CYP1A2CYP2A6HRH3LOXL2
SCHEMBL28414434 0.87 TAAR1 (0.52) TAAR1CYP1A2CYP2A6HRH3LOXL2
SCHEMBL28196044 0.85 TAAR1 (0.50) TAAR1CYP1A2CYP2A6HRH3LOXL2
P-Xylene SCHEMBL27449807 0.83 LOXL2 (0.74) TAAR1CYP1A2CYP2A6LOXL2ACHE
SCHEMBL14959428 0.83 NFE2L2 (0.52) TAAR1CYP1A2CYP2A6HRH3LOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6649627-B1 N-Substituted with 1- (pyrid-2-yl)-piperidine-4-yl radical; gastrointestinal and psychological disorder treatment; antidiabetic tocolytic, and antidepressant agents; irritable bowel syndrome, glaucoma and dysmenorrhoea SANOFI-SYNTHELABO (FR) 2003-11-18 — — US disclosed
EP-1087961-B1 PHENOXYLPROPANOLAMINES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME SANOFI SYNTHELABO (FR) 2002-08-14 — — EP disclosed
EP-1087961-A1 PHENOXYLPROPANOLAMINES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME SANOFI-SYNTHELABO (FR) 2001-04-04 — — EP disclosed
WO-1999065895-A1 PHENOXYLPROPANOLAMINES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME SANOFI-SYNTHELABO (FR) 1999-12-23 — — WO disclosed
EP-0434213-B1 Monosubstituted dithiooxamide compounds and their use MINNESOTA MINING & MFG (US) 1995-04-05 — — EP disclosed
US-5124308-A Reacts with transition metal salt for carbonless paper copying MINNESOTA MINING AND MANUFACTURING COMPANY 1992-06-23 — — US disclosed
US-5041654-A Transamination in wallach reaction; controlling temperature; reactant amine concentration MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1991-08-20 — — US disclosed
EP-0434213-A1 Monosubstituted dithiooxamide compounds and their use MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1991-06-26 — — EP disclosed
EP-0431783-A1 Preparation of monosubstituted dithiooxamide compounds MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1991-06-12 — — EP disclosed
Send feedback